The vaccine, produced by the Johnson & Johnson-owned Belgium-based pharmaceutical company Janssen, has shown up 85 percent effectiveness against the COVID-19 disease. The US federal regulator earlier paused for a short period the use of the compound due to a deadly but extremely rare side effect.
